BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21593729)

  • 1. Is PrP the road to ruin?
    Barton KA; Caughey B
    EMBO J; 2011 May; 30(10):1882-4. PubMed ID: 21593729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.
    Resenberger UK; Harmeier A; Woerner AC; Goodman JL; Müller V; Krishnan R; Vabulas RM; Kretzschmar HA; Lindquist S; Hartl FU; Multhaup G; Winklhofer KF; Tatzelt J
    EMBO J; 2011 May; 30(10):2057-70. PubMed ID: 21441896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor-1 α regulates prion protein expression to protect against neuron cell damage.
    Jeong JK; Seo JS; Moon MH; Lee YJ; Seol JW; Park SY
    Neurobiol Aging; 2012 May; 33(5):1006.e1-10. PubMed ID: 22036844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.
    Choi CJ; Anantharam V; Martin DP; Nicholson EM; Richt JA; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2010 Jun; 115(2):535-46. PubMed ID: 20176619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spongiform pathology in mouse CNS lacking 'neuropathy target esterase' and cellular prion protein.
    Rosenbluth J; Schiff R; Lam P; Nuriel T; Chao MV
    Neurobiol Dis; 2009 Sep; 35(3):433-7. PubMed ID: 19524041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
    Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
    FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
    Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
    J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities.
    Chiesa R; Piccardo P; Biasini E; Ghetti B; Harris DA
    J Neurosci; 2008 Dec; 28(49):13258-67. PubMed ID: 19052217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of novel C-terminal prion protein fragments and peptides harbouring disease-related C-terminal mutations.
    Daniels M; Cereghetti GM; Brown DR
    Eur J Biochem; 2001 Dec; 268(23):6155-64. PubMed ID: 11733010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prion].
    Sakaguchi S
    Uirusu; 2002 Jun; 52(1):163-7. PubMed ID: 12227168
    [No Abstract]   [Full Text] [Related]  

  • 11. Physiological and pathological functions of the prion protein homologue Dpl.
    Behrens A
    Br Med Bull; 2003; 66():35-42. PubMed ID: 14522847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding.
    Carulla P; Bribián A; Rangel A; Gavín R; Ferrer I; Caelles C; Del Río JA; Llorens F
    Mol Biol Cell; 2011 Sep; 22(17):3041-54. PubMed ID: 21757544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermostability as a highly dependent prion strain feature.
    Marín-Moreno A; Aguilar-Calvo P; Moudjou M; Espinosa JC; Béringue V; Torres JM
    Sci Rep; 2019 Aug; 9(1):11396. PubMed ID: 31388046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurometals in the Pathogenesis of Prion Diseases.
    Kawahara M; Kato-Negishi M; Tanaka KI
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutated but Not Deleted Ovine PrP(C) N-Terminal Polybasic Region Strongly Interferes with Prion Propagation in Transgenic Mice.
    Khalifé M; Reine F; Paquet-Fifield S; Castille J; Herzog L; Vilotte M; Moudjou M; Moazami-Goudarzi K; Makhzami S; Passet B; Andréoletti O; Vilette D; Laude H; Béringue V; Vilotte JL
    J Virol; 2016 Feb; 90(3):1638-46. PubMed ID: 26608316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The toxicity of a mutant prion protein is cell-autonomous, and can be suppressed by wild-type prion protein on adjacent cells.
    Biasini E; Turnbaugh JA; Massignan T; Veglianese P; Forloni G; Bonetto V; Chiesa R; Harris DA
    PLoS One; 2012; 7(3):e33472. PubMed ID: 22428057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sheddase ADAM10 is a potent modulator of prion disease.
    Altmeppen HC; Prox J; Krasemann S; Puig B; Kruszewski K; Dohler F; Bernreuther C; Hoxha A; Linsenmeier L; Sikorska B; Liberski PP; Bartsch U; Saftig P; Glatzel M
    Elife; 2015 Feb; 4():. PubMed ID: 25654651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurochemical nature of PrP(c)-containing cells in the rat brain.
    Moleres FJ; Velayos JL
    Brain Res; 2007 Oct; 1174():143-51. PubMed ID: 17854776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxic effect of the complex of the ovine prion protein (OvPrP(C)) and RNA on the cultured rat cortical neurons.
    Liu ML; Wen JJ; Xu XF; Zhao DM
    Neurochem Res; 2011 Oct; 36(10):1863-9. PubMed ID: 21607610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PrP expression and replication by Schwann cells: implications in prion spreading.
    Follet J; Lemaire-Vieille C; Blanquet-Grossard F; Podevin-Dimster V; Lehmann S; Chauvin JP; Decavel JP; Varea R; Grassi J; Fontès M; Cesbron JY
    J Virol; 2002 Mar; 76(5):2434-9. PubMed ID: 11836421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.